Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Director departure
|
|
Principia Biopharma Inc. (PRNB)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 09/28/2020 |
4
| Tomasello Shawn (Director) has filed a Form 4 on Principia Biopharma Inc.|
Txns:
| Disposed/sold 20,475 options to buy
@ $36.79, valued at
$753.3k
Disposed/sold 10,240 options to buy
@ $62.66, valued at
$641.6k
|
|
| 09/28/2020 |
4
| Machado Patrick (Director) has filed a Form 4 on Principia Biopharma Inc.|
Txns:
| Disposed/sold 20,475 options to buy
@ $31.77, valued at
$650.5k
Disposed/sold 10,240 options to buy
@ $31.77, valued at
$325.3k
Disposed/sold 10,240 options to buy
@ $62.66, valued at
$641.6k
|
|
| 09/28/2020 |
4
| George Simeon (Director) has filed a Form 4 on Principia Biopharma Inc.|
Txns:
| Unknown transaction of 2,982,855 shares
@ $100, valued at
$298.3M
Disposed/sold 28,623 warrants
@ $0
Disposed/sold 20,475 options to buy
@ $0
Disposed/sold 10,240 options to buy
@ $0 |
|
| 09/28/2020 |
4
| Lin Shao-Lee (Director) has filed a Form 4 on Principia Biopharma Inc.|
Txns:
| Disposed/sold 20,475 options to buy
@ $27.81, valued at
$569.4k
Disposed/sold 10,240 options to buy
@ $31.77, valued at
$325.3k
Disposed/sold 10,240 options to buy
@ $62.66, valued at
$641.6k
|
|
| 09/28/2020 |
4
| Becker Daniel J. (Director) has filed a Form 4 on Principia Biopharma Inc.|
Txns:
| Unknown transaction of 667,600 shares
@ $100, valued at
$66.8M
Disposed/sold 20,475 options to buy
@ $17, valued at
$348.1k
Disposed/sold 10,240 options to buy
@ $31.77, valued at
$325.3k
Disposed/sold 10,240 options to buy
@ $62.66, valued at
$641.6k
|
|
| 09/28/2020 |
4
| Colowick Alan (Director) has filed a Form 4 on Principia Biopharma Inc.|
Txns:
| Disposed/sold 47,724 options to buy
@ $4.542, valued at
$216.8k
Disposed/sold 20,475 options to buy
@ $17, valued at
$348.1k
Disposed/sold 10,240 options to buy
@ $31.77, valued at
$325.3k
Disposed/sold 10,240 options to buy
@ $62.66, valued at
$641.6k
|
|
| 09/28/2020 |
4
| Wolff Stefani (Chief Development Officer) has filed a Form 4 on Principia Biopharma Inc.|
Txns:
| Gifted 5,504 shares
@ $0
Unknown transaction of 13,592 shares
@ $100, valued at
$1.4M
Disposed/sold 30,056 options to buy
@ $4.542, valued at
$136.5k
Disposed/sold 16,843 options to buy
@ $7.2671, valued at
$122.4k
Disposed/sold 22,017 options to buy
@ $11.3549, valued at
$250k
Disposed/sold 55,042 options to buy
@ $17, valued at
$935.7k
Disposed/sold 60,000 options to buy
@ $35.42, valued at
$2.1M
Disposed/sold 55,000 options to buy
@ $67.31, valued at
$3.7M
|
|
| 09/28/2020 |
4
| Thomas Dolca (Chief Medical Officer) has filed a Form 4 on Principia Biopharma Inc.|
Txns:
| Unknown transaction of 2,207 shares
@ $100, valued at
$220.7k
Disposed/sold 168,057 options to buy
@ $23.77, valued at
$4M
Disposed/sold 60,000 options to buy
@ $35.42, valued at
$2.1M
Disposed/sold 55,000 options to buy
@ $67.31, valued at
$3.7M
|
|
| 09/28/2020 |
4
| Hardiman Roy C. (Chief Business Officer) has filed a Form 4 on Principia Biopharma Inc.|
Txns:
| Unknown transaction of 117,761 shares
@ $100, valued at
$11.8M
Unknown transaction of 1,916 shares
@ $100, valued at
$191.6k
Disposed/sold 11,519 options to buy
@ $7.2671, valued at
$83.7k
Disposed/sold 44,034 options to buy
@ $11.3549, valued at
$500k
Disposed/sold 60,000 options to buy
@ $35.42, valued at
$2.1M
Disposed/sold 55,000 options to buy
@ $67.31, valued at
$3.7M
|
|
| 09/28/2020 |
4
| CHAI CHRISTOPHER Y (CFO) has filed a Form 4 on Principia Biopharma Inc.|
Txns:
| Unknown transaction of 3,799 shares
@ $100, valued at
$379.9k
Unknown transaction of 3,302 shares
@ $100, valued at
$330.2k
Disposed/sold 56,982 options to buy
@ $2.9977, valued at
$170.8k
Disposed/sold 24,769 options to buy
@ $3.1794, valued at
$78.8k
Disposed/sold 29,723 options to buy
@ $4.7236, valued at
$140.4k
Disposed/sold 13,210 options to buy
@ $4.9961, valued at
$66k
Disposed/sold 34,677 options to buy
@ $7.2671, valued at
$252k
Disposed/sold 44,034 options to buy
@ $11.3549, valued at
$500k
Disposed/sold 60,000 options to buy
@ $35.42, valued at
$2.1M
Disposed/sold 55,000 options to buy
@ $67.31, valued at
$3.7M
|
|
| 09/28/2020 |
4
| Goldstein David M (Chief Scientific Officer) has filed a Form 4 on Principia Biopharma Inc.|
Txns:
| Unknown transaction of 31,826 shares
@ $100, valued at
$3.2M
Disposed/sold 12,960 options to buy
@ $3.1794, valued at
$41.2k
Disposed/sold 13,210 options to buy
@ $4.7236, valued at
$62.4k
Disposed/sold 8,807 options to buy
@ $4.7236, valued at
$41.6k
Disposed/sold 15,412 options to buy
@ $4.9961, valued at
$77k
Disposed/sold 22,017 options to buy
@ $4.9961, valued at
$110k
Disposed/sold 34,677 options to buy
@ $7.2671, valued at
$252k
Disposed/sold 44,034 options to buy
@ $11.3549, valued at
$500k
Disposed/sold 60,000 options to buy
@ $35.42, valued at
$2.1M
Disposed/sold 75,000 options to buy
@ $67.31, valued at
$5M
|
|
| 09/28/2020 |
4
| Babler Martin (President, CEO) has filed a Form 4 on Principia Biopharma Inc.|
Txns:
| Unknown transaction of 1,023 shares
@ $100, valued at
$102.3k
Unknown transaction of 39,179 shares
@ $100, valued at
$3.9M
Unknown transaction of 18,355 shares
@ $100, valued at
$1.8M
Disposed/sold 255 warrants
@ $8.9931, valued at
$2.3k
Disposed/sold 50,795 options to buy
@ $1.9076, valued at
$96.9k
Disposed/sold 85,728 options to buy
@ $2.9977, valued at
$257k
Disposed/sold 110,085 options to buy
@ $3.1794, valued at
$350k
Disposed/sold 83,004 options to buy
@ $4.7236, valued at
$392.1k
Disposed/sold 60,546 options to buy
@ $4.9961, valued at
$302.5k
Disposed/sold 115,590 options to buy
@ $7.2671, valued at
$840k
Disposed/sold 187,144 options to buy
@ $11.3549, valued at
$2.1M
|
|
| 09/22/2020 |
4
| Hardiman Roy C. (Chief Business Officer) has filed a Form 4 on Principia Biopharma Inc.|
Txns:
| Sold 5,000 shares
@ $99.9835, valued at
$499.9k
Exercised 2,758 options to buy
@ $4.7236, valued at
$13k
Exercised 2,242 options to buy
@ $7.2671, valued at
$16.3k
|
|
| 08/20/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/20/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/20/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/12/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/17/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/02/2020 |
4
| Colowick Alan (Director) has filed a Form 4 on Principia Biopharma Inc.|
Txns:
| Sold 7,500 shares
@ $60, valued at
$450k
Exercised 7,500 options to buy
@ $4.542, valued at
$34.1k
|
|
| 06/25/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/17/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/15/2020 |
4
| Hardiman Roy C. (Chief Business Officer) has filed a Form 4 on Principia Biopharma Inc.|
Txns:
| Sold 1,595 shares
@ $59.9003, valued at
$95.5k
Sold 2,542 shares
@ $61.6169, valued at
$156.6k
Sold 863 shares
@ $62.1289, valued at
$53.6k
Exercised 5,000 options to buy
@ $4.7236, valued at
$23.6k
|
|
| 06/08/2020 |
4
| Tomasello Shawn (Director) has filed a Form 4 on Principia Biopharma Inc.|
Txns:
| Granted 10,240 options to buy
@ $62.66, valued at
$641.6k
|
|
| 06/08/2020 |
4
| Machado Patrick (Director) has filed a Form 4 on Principia Biopharma Inc.|
Txns:
| Granted 10,240 options to buy
@ $62.66, valued at
$641.6k
|
|
| 06/08/2020 |
4
| George Simeon (Director) has filed a Form 4 on Principia Biopharma Inc.|
Txns:
| Granted 10,240 options to buy
@ $62.66, valued at
$641.6k
|
|
| 06/08/2020 |
4
| Lin Shao-Lee (Director) has filed a Form 4 on Principia Biopharma Inc.|
Txns:
| Granted 10,240 options to buy
@ $62.66, valued at
$641.6k
|
|
| 06/08/2020 |
4
| Becker Daniel J. (Director) has filed a Form 4 on Principia Biopharma Inc.|
Txns:
| Granted 10,240 options to buy
@ $62.66, valued at
$641.6k
|
|
| 06/08/2020 |
4
| Colowick Alan (Director) has filed a Form 4 on Principia Biopharma Inc.|
Txns:
| Granted 10,240 options to buy
@ $62.66, valued at
$641.6k
|
|
| 05/21/2020 |
4
| CHAI CHRISTOPHER Y (CFO) has filed a Form 4 on Principia Biopharma Inc.|
Txns:
| Sold 7,500 shares
@ $65.1024, valued at
$488.3k
Exercised 5,675 options to buy
@ $2.9977, valued at
$17k
|
|
| 05/08/2020 |
4
| Goldstein David M (Chief Scientific Officer) has filed a Form 4 on Principia Biopharma Inc.|
Txns:
| Sold 3,281 shares
@ $59.9616, valued at
$196.7k
Sold 2,719 shares
@ $60.3925, valued at
$164.2k
Exercised 6,000 options to buy
@ $2.9977, valued at
$18k
|
|
| 05/05/2020 |
4
| Colowick Alan (Director) has filed a Form 4 on Principia Biopharma Inc.|
Txns:
| Sold 840 shares
@ $60.0675, valued at
$50.5k
Sold 6,660 shares
@ $60, valued at
$399.6k
Exercised 840 options to buy
@ $4.542, valued at
$3.8k
Exercised 6,660 options to buy
@ $4.542, valued at
$30.2k
|
|
| 03/18/2020 |
4
| Wolff Stefani (Chief Development Officer) has filed a Form 4 on Principia Biopharma Inc.|
Txns:
| Sold 1,754 shares
@ $45.7196, valued at
$80.2k
Sold 3,750 shares
@ $46.3569, valued at
$173.8k
Exercised 5,504 options to buy
@ $4.542, valued at
$25k
|
|
| 03/17/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/05/2020 |
4
| Wolff Stefani (Chief Development Officer) has filed a Form 4 on Principia Biopharma Inc.|
Txns:
| Granted 55,000 options to buy
@ $67.31, valued at
$3.7M
|
|
|
|
|